Vanda Pharmaceuticals Inc.
VNDANASDAQHealthcareBiotechnology
As of Oct 16, 2026 close
- Market cap
- $255.36M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $4.20$9.94
- Volume (live)
- -
- Avg. volume (3M)
- 1.02M
Vanda Pharmaceuticals (VNDA) Stock Price & Financial Analysis
Vanda Pharmaceuticals Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $4.00 - $4.27 |
|---|---|
| 52-Week High | $9.94 |
| 52-Week Low | $4.20 |
| Open | $4.25 |
| Volume (last close) | 1.05M |
| Average Volume (3M) | 1.02M |
| Revenue (TTM) | 215.72M |
|---|---|
| Net Income (TTM) | -274.85M |
| Free Cash Flow (TTM) | -143.00M |
| EPS (TTM) | −$4.62 |
| Profit Margin | -127.41% |
| Operating Margin | -86.07% |
| Return on Equity (ROE) | -124.83% |
| Debt to Equity | 0.10 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 255.36M |
|---|---|
| Shares Outstanding | 60.23M |
| Price to Sales (P/S) | 1.18 |
| Price to Book (P/B) | 1.16 |
| EV/EBITDA | -1.34 |
| 50-Day MA | $5.07 |
|---|---|
| 200-Day MA | $6.44 |
| 1-Year Change | −19.54% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
Vanda Pharmaceuticals at a Glance
As of the Oct 16, 2026 close, Vanda Pharmaceuticals (VNDA) has a market capitalization of $255.36M. The stock trades at 1.2× sales. Over the trailing twelve months it lost $274.85M on revenue of $215.72M and burned $143.00M of free cash flow. Revenue grew 6.0% year over year.
As of its latest reported balance sheet, it holds $55.88M in cash and securities against $22.83M of debt, a net cash position of $33.05M.
Vanda Pharmaceuticals does not currently pay a dividend.
The share price is down 19.5% over the past year. At $4.04 (the Oct 16, 2026 close) it sits near the bottom of its 52-week range of $4.20 to $9.94, below its 200-day moving average of $6.44.
Based on 5 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $13.25, 228.1% above the Oct 16, 2026 close.
Frequently Asked Questions About Vanda Pharmaceuticals
What is the current stock price for VNDA?
As of the Oct 16, 2026 close, VNDA stock trades at $4.04. The 52-week range is $4.20–$9.94, with a day range of $4.00–$4.27.
What is the P/E ratio for VNDA?
The P/E ratio (Price-to-Earnings) for VNDA is shown in the Key Statistics section. This valuation metric helps compare Vanda Pharmaceuticals Inc. to industry peers.
Does VNDA pay dividends?
Vanda Pharmaceuticals does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for VNDA?
Based on ratings from 5 professional analysts over the last 90 days, the consensus for VNDA is Buy. The average 12-month price target is $13.25, a 228.1% upside from the Oct 16, 2026 close of $4.04.
What is the market cap of VNDA?
As of the Oct 16, 2026 close, Vanda Pharmaceuticals's market capitalization is $243.2M, classifying it as a micro-cap company. Vanda Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.